ArticleScientific reports2020

Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer.

Gustavo A Arias-Pinilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.